Cargando…
Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer
Introduction: Prostate cancer is the second leading cause of cancer-related death among American men. Prostate tumor cells exhibit significant tropism for the bone and once metastasis occurs, survival rates fall significantly. Current treatment options are not curative and focus on symptom managemen...
Autores principales: | Kumar, Shreya, Mulia, Grace E., Figueiredo, Marxa L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568464/ https://www.ncbi.nlm.nih.gov/pubmed/37842640 http://dx.doi.org/10.3389/fmolb.2023.1259336 |
Ejemplares similares
-
A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications
por: Salameh, Janelle Wesleyn, et al.
Publicado: (2022) -
Enhancing Prednisone-Based Arthritis Therapy with Targeted IL-27 Gene Delivery
por: Marin, Adriana A., et al.
Publicado: (2022) -
Intrinsic Genetic and Transcriptomic Patterns Reflect Tumor Immune Subtypes Facilitating Exploring Possible Combinatory Therapy
por: Xu, Yong, et al.
Publicado: (2020) -
Linear Peptides—A Combinatorial Innovation in the Venom of Some Modern Spiders
por: Kuhn-Nentwig, Lucia, et al.
Publicado: (2021) -
Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development
por: Cardoso, Fernanda C., et al.
Publicado: (2022)